Featured Doctor

Anthony James Comerota, MD, FACS, FRACS (HON.), FACC A colleague had this to say: “Dr. Comerato has been a leading researcher in the basic science of venous disease and a leading force in new techniques for thrombolysis in DVT patients.” In your opinion, which area of research is yielding the ...

Edward G. Mackay ll, MD A colleague had this to say: “Dr. Mackay has served the field in numerous ways with active participation in ACP, ISET, IVC and IVVC through both instruction and live presentations. One of his next challenges will be to Co-Chair the 2009 Dominican Republic Venous Masters Pr ...

Frank Veith, MD A colleague had this to say: “Frank has been running the VEITHsymposium for over 35 years and it has steadily grown because of his personal efforts to advance the education of physicians in multiple specialties. His successes have been the successes of all those who have learned f ...

Helane S. Fronek, MD, FACP, FACPh A colleague had this to say: “Helane is a wonderful educator and teacher - she has spread her enthusiasm for the field through countless hours and dedication to the ACP and affiliated projects.” Where do you see the specialty of phlebology in 5 years? 10 years ...

Hugo Partsch, Univ. Prof., MD A colleague had this to say: “Professor Partsch has successfully established an international organization of medical professionals in phlebology and industry with the objective of proving consensus guidance on the various aspects of compression therapy in phlebology

James Theodore King, MD A colleague had this to say: “Ted represents phlebology as a leader with research and presentations at ACP meetings, not to mention numerous organizations internationally. Furthermore, he is instrumental to the growth of the specialty and ACP with generous contributions to

JJ Guex, MD, FACPh A colleague had this to say: “JJ Guex is one of the most creative thinkers in the field; he questions everything, and welcomes everyone. His research is relevant, unique and intriguing.” Where do you see the specialty of phlebology in 5 years? 10 years? Much more simple, pa ...

John J. Bergan, MD, FACS, Hon, FRCS (Eng.), FACPh A colleague had this to say: “Simply one of the best spoken and most knowledgeable on venous disease and the various treatment options, Dr. Bergan brought validity to the use of sclerotherapy as an alternative to venous surgery. His brilliant mind ...

John Mauriello A colleague had this to say: “John Mauriello is a Master; I consider him one of the pioneers in modern phlebology. He cares about the profession and is dedicated and committed to its advancement. He was doing phlebology long before EVLA evolved. John is one of the original Fellows

Jose I. Almeida, MD A colleague had this to say: “Jose has dedicated his life to advancing phlebology education for all who seek it - regardless of their medical backgrounds.” Where do you see the specialty of phlebology in 5 years? 10 years? The specialty should continue to evolve into a coh ...